These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3966545)

  • 21. Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL.
    Shafrir E; Levy E; Deckelbaum R
    Nephron; 1990; 56(1):24-9. PubMed ID: 2234246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hyperlipidemia of the nephrotic syndrome.
    Appel GB; Valeri A; Appel AS; Blum C
    Am J Med; 1989 Nov; 87(5N):45N-50N. PubMed ID: 2486547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperlipidemia in childhood nephrotic syndrome.
    Thabet MA; Salcedo JR; Chan JC
    Pediatr Nephrol; 1993 Oct; 7(5):559-66. PubMed ID: 8251323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
    Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
    Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins.
    Gherardi E; Vecchia L; Calandra S
    Exp Mol Pathol; 1980 Apr; 32(2):128-42. PubMed ID: 7364013
    [No Abstract]   [Full Text] [Related]  

  • 26. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
    Davies RW; Staprans I; Hutchison FN; Kaysen GA
    J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hyperlipidemia of the nephrotic syndrome.
    Black RM
    N Engl J Med; 1985 Nov; 313(20):1298-9. PubMed ID: 4058520
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipid synthesis and apolipoprotein gene expression in hepatocytes in primary culture from (puromycin-induced) nephrotic rats.
    el Boustani S; Ribeiro A; Janvier B; Loriette C; Bensman R; Druet P; Chambaz J; Mangeney M
    Eur J Clin Invest; 1993 Apr; 23(4):211-8. PubMed ID: 8500513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
    Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
    Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC
    Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome.
    Tarugi P; Nicolini S; Albertazzi L; Marchi L; Calandra S; Salvati P
    Aging (Milano); 1994 Oct; 6(5):381-90. PubMed ID: 7893785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid metabolism in primary cultured hepatocytes from daunomycin-nephrotic rats.
    Gomikawa S; Takamitu Y
    Miner Electrolyte Metab; 1998; 24(5):330-6. PubMed ID: 9705569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of Astragalus Angelica mixture on serum lipids and glomerulosclerosis in rats with nephrotic syndrome].
    Lu Y; Li JZ; Zheng X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Aug; 17(8):478-80. PubMed ID: 10322835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
    Vaziri ND; Kim CH; Phan D; Kim S; Liang K
    Kidney Int; 2004 Jul; 66(1):262-7. PubMed ID: 15200432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6 Keto prostaglandin F1alpha plasma levels in aminonucleoside nephrosis in the rat.
    Garin EH; Sausville PJ; Richard GA
    Prostaglandins; 1982 Mar; 23(3):391-5. PubMed ID: 6896583
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of lipoproteins on plasma viscosity.
    Seplowitz AH; Chien S; Smith FR
    Atherosclerosis; 1981; 38(1-2):89-95. PubMed ID: 7470209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hyperlipidemia with probucol reduces proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T; Mamo JC; Ohnami K; Sugisaki T
    Nephron; 1990; 54(4):358-9. PubMed ID: 2325806
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.